Oventus Medical Limited announced consolidated earnings results for the half-year ended 31 December 2018. For the half year, the company reported revenue of $151,757 against $135,736 for the same period a year ago. Loss for the year attributable to members of the company was $3,662,999 against $2,769,815 for the same period a year ago. Basic loss per share was $3.46 against $3.00 for the same period a year ago.